MERCK Kommanditgesellschaft auf Aktien logo

MERCK Kommanditgesellschaft auf Aktien (0O14)

Market Open
20 Jan, 15:37
141. 70
-0.2
-0.14%
- Market Cap
23.04 P/E Ratio
2.39% Div Yield
12,212 Volume
0 Eps
141.9
Previous Close
Day Range
140.95 142
Year Range
136.15 176.85
Earnings results expected in 44 days

Summary

0O14 trading today lower at €141.7, a decrease of 0.14% from yesterday's close, completing a monthly increase of 2.18% or €3.02. Over the past 12 months, 0O14 stock gained 2.18%.
0O14 is not paying dividends to its shareholders.
The last earnings report, released on Nov 14, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 1%, based on the last three reports. The next scheduled earnings report is due on Mar 06, 2025.
The stock of the company had never split.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on LSE (EUR).
Want to track 0O14 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

0O14 Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.

MERCK Kommanditgesellschaft auf Aktien Dividends

0O14 is not paying dividends to its shareholders.

MERCK Kommanditgesellschaft auf Aktien Earnings

6 Mar 2025 (44 Days) Date
-
Cons. EPS
-
EPS
14 Nov 2024 Date
-
Cons. EPS
-
EPS
1 Aug 2024 Date
-
Cons. EPS
1.4
EPS
15 May 2024 Date
-
Cons. EPS
1.6
EPS
26 Apr 2024 Date
-
Cons. EPS
-
EPS
0O14 is not paying dividends to its shareholders.
6 Mar 2025 (44 Days) Date
-
Cons. EPS
-
EPS
14 Nov 2024 Date
-
Cons. EPS
-
EPS
1 Aug 2024 Date
-
Cons. EPS
1.4
EPS
15 May 2024 Date
-
Cons. EPS
1.6
EPS
26 Apr 2024 Date
-
Cons. EPS
-
EPS

FAQ

What Is the MERCK Kommanditgesellschaft auf Aktien(0O14) Stock Price Today?

The 0O14 stock price today is €141.70.

What Stock Exchange Does MERCK Kommanditgesellschaft auf Aktien Trade On?

MERCK Kommanditgesellschaft auf Aktien is listed and trades on the XWBO.

What Is the Stock Symbol for MERCK Kommanditgesellschaft auf Aktien?

The stock symbol for MERCK Kommanditgesellschaft auf Aktien is "0O14".

Does MERCK Kommanditgesellschaft auf Aktien Pay Dividends? What's The Current Dividend Yield?

0O14 is not paying dividends to its shareholders.

What Is the MERCK Kommanditgesellschaft auf Aktien Market Cap?

As of today, MERCK Kommanditgesellschaft auf Aktien does not have a market cap available.

What is MERCK Kommanditgesellschaft auf Aktien Earnings Per Share?

The MERCK Kommanditgesellschaft auf Aktien EPS is 0.

What Is the Next MERCK Kommanditgesellschaft auf Aktien Earnings Date?

MERCK Kommanditgesellschaft auf Aktien will release its next earnings report on Mar 06, 2025.

Did MERCK Kommanditgesellschaft auf Aktien had any splits?

No, MERCK Kommanditgesellschaft auf Aktien has never had a stock split.

MERCK Kommanditgesellschaft auf Aktien Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Ms. Belen Garijo Lopez M.D. CEO
LSE Exchange
- ISIN
US Country
62,908 Employees
23 Aug 1970 Last Dividend
- Last Split
- IPO Date

Overview

Merck KGaA is a prominent science and technology entity based in Germany, spanning its operations through diversified sectors such as Life Science, Healthcare, and Electronics. As of its inception in 1668, the company has distinguished itself by contributing significantly to academic, biotech, pharmaceutical, and industrial fields with its comprehensive range of tools, chemicals, and technology solutions. It is an influential subsidiary of E. Merck KGaA, with its headquarters located in Darmstadt, Germany. Through its international collaborations and in-licensing agreements with companies like Debiopharm International SA, Jiangsu Hengrui Pharmaceuticals Co. Ltd., and Abbisko Therapeutics Co. Ltd., Merck KGaA continues to bolster its position in developing innovative treatments in areas such as oncology, neurology, and various other critical disease sectors.

Products and Services

  • Life Science Solutions

    Merck KGaA offers an extensive suite of products tailored for the Life Science industry, catering to academic labs, biotech, and pharmaceutical manufacturers. This includes process development expertise, technologies for continuous bioprocessing, testing kits, chemical reagents, and services designed for air, water, and soil analysis. They also provide tools that assess the nutritional value and identify quality inconsistencies, aiming to support the entire biopharmaceutical manufacturing value chain.

  • Healthcare and Biopharmaceuticals

    The company plays a pivotal role in the healthcare sector by discovering, developing, manufacturing, and marketing a broad portfolio of prescription drugs and biopharmaceutical products. These offerings are directed toward treating conditions in oncology, neurology and immunology, fertility, endocrinology, cardiovascular diseases, diabetes, thyroid disorders, and multiple sclerosis. Moreover, it includes general medicines along with injection devices and disease monitoring software, stressing the importance of comprehensive patient care.

  • Electronics Segment

    Merck KGaA extends its expertise to the semiconductor and display industries by supplying critical materials and solutions for surface design. This encompasses delivery systems and services, as well as innovative surface solutions like cosmetics, effect pigments, and functional solutions. Their contributions are vital for the development and manufacturing processes in the electronics sector, showcasing their versatility and capacity to meet diverse industry needs.

  • In-licensing Agreements and Collaborations

    The company has established several significant in-licensing agreements and collaborations aimed at the development and commercialization of drug candidates. This includes partnerships for targeting conditions like head and neck cancer, metastatic colorectal cancer, and tenosynovial giant cell tumor. Such endeavors signify Merck KGaA's commitment to addressing global health challenges through innovation and strategic partnerships.

Contact Information

Address: Frankfurter Strasse 250, Darmstadt, Germany, 64293
Phone: 49 6151 72 0